Understanding Sugar-Sweetened Beverages (SSB) and Colorectal Cancer (CRC)

NCT ID: NCT06669923

Last Updated: 2024-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-11-15

Study Completion Date

2030-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will recruit and consent approximately 120 subjects in the baseline study until the follow-up study recruitment goals of 20 subjects is met. This pilot proposal to: Aim 1) assess the feasibility of conducting a randomized controlled trial of iSIPsmarter among high-risk patients with newly detected large colorectal adenoma to reduce Sugar-Sweetened Beverages (SSB) consumption, and Aim 2) examine the investigators' central hypothesis that SSBs contribute to racial disparities in the development of side-specific colon neoplasia via differentially impacting epigenetic aging and methylation of right vs. left normal colon tissues of African-Americans (AA) vs European-Americans (EA). In order to do so, the investigators will first conduct a study to collect baseline information from eligible and interested participants. Behavioral, lifestyle, and genetic information will be collected from participants undergoing a colonoscopy with large polypectomy removal to set up a biobank. The participants enrolled in this study will then be screened for their interest and eligibility in participating in the follow-up study, a randomized iSIPsmarter intervention trial. The investigators will enroll 20 patients in the follow-up study (1:1 ratio intervention vs. control; equal number of AAs and EAs) with newly detected/resected large colorectal adenomas to collect normal colon tissue biopsies pre- and post-iSIPsmarter intervention and test the investigators' hypotheses.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Baseline

Baseline study collects baseline data and screens for potential participants for the follow-up study.

Group Type NO_INTERVENTION

No interventions assigned to this group

Follow Up - Patient Education Group

Group Type SHAM_COMPARATOR

Patient Education

Intervention Type BEHAVIORAL

website with information about cancer screening and prevention (e.g. screening tests for seven types of cancer)

Follow Up - iSIPsmarter Program Group

Group Type EXPERIMENTAL

iSIPsmarter Program

Intervention Type BEHAVIORAL

web-based behavioral intervention to reduce sugary drink intake

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

iSIPsmarter Program

web-based behavioral intervention to reduce sugary drink intake

Intervention Type BEHAVIORAL

Patient Education

website with information about cancer screening and prevention (e.g. screening tests for seven types of cancer)

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Sugary Drink Program Cancer Prevention Program

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients scheduled for a colonoscopy (large polyp removal)
* Patients 18+


* Regular access (\<1/week) to the internet.
* Drink more than recommended amount of sugar-sweetened beverages per day (assessed from participant's responses to the Beverage Questionnaire section (BEVQ-15) of the Computer Administered Phone Interview (CAPI), from the Baseline study).

Exclusion Criteria

* Subjects who do not speak English
* Subjects diagnosed with inflammatory bowel disorder
* Subjects diagnosed with cancer (except non-melanoma skin cancer)
* Subjects taking blood thinners at time of colonoscopy (except 325 mg daily aspirin)

Follow-up Study:

In order to be eligible to participate in the f/up study, an individual must meet all of the criteria for the Baseline study AND:
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Virginia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Li Li

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Li Li, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

UVA, Dept of Family Medicine

Jamie Zoellner, PhD, RD

Role: PRINCIPAL_INVESTIGATOR

UVA, Dept of Public Health Sciences

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Samyukta Venkatesh, BA

Role: CONTACT

4342434983

Donna-Jean Brock, MA

Role: CONTACT

434-962-5870

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HSR230101

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prebiotics in Rectal Cancer
NCT05516641 UNKNOWN NA
Colorectal Cancer Control in Appalachian Churches
NCT00137683 WITHDRAWN PHASE2/PHASE3